PERRIGO CO
10-Q, EX-27, 2000-10-25
PHARMACEUTICAL PREPARATIONS
Previous: PERRIGO CO, 10-Q, EX-10.(C), 2000-10-25
Next: OPPENHEIMER CHAMPION INCOME FUND/NY, 497, 2000-10-25



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-02-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          33,414
<SECURITIES>                                         0
<RECEIVABLES>                                  109,426
<ALLOWANCES>                                     6,828
<INVENTORY>                                    126,074
<CURRENT-ASSETS>                               304,645
<PP&E>                                         343,964
<DEPRECIATION>                                 150,441
<TOTAL-ASSETS>                                 521,497
<CURRENT-LIABILITIES>                          139,010
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       102,777
<OTHER-SE>                                     259,821
<TOTAL-LIABILITY-AND-EQUITY>                   521,497
<SALES>                                        193,333
<TOTAL-REVENUES>                               193,333
<CGS>                                          146,394
<TOTAL-COSTS>                                  146,394
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 1,293
<INTEREST-EXPENSE>                                 236
<INCOME-PRETAX>                                 16,607
<INCOME-TAX>                                     6,073
<INCOME-CONTINUING>                             10,534
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    10,534
<EPS-BASIC>                                       0.14
<EPS-DILUTED>                                     0.14


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission